Almost all currently available treatments for inflammatory bowel disease (IBD) act by
inhibiting inflammation, often blocking specific inflammatory molecules. However, given the …

Ulcerative colitis (UC) is a chronic inflammatory disease with an underlying excessive
immune response directed against resident microbiota and/or dietary antigens. Both innate …

COVID-19, disease caused by the new coronavirus, SARS-CoV-2, appeared in the end of
2019 and was rapidly spread in most countries. This respiratory virus has different symptoms …

Ulcerative colitis (UC) is a chronic inflammatory bowel disease related to intestinal
dysbiosis. Luteolin has been reported to reduce inflammation. However, it remains unclear …

Inflammatory bowel disease (IBD), comprising Crohn's disease (CD) and ulcerative colitis
(UC), is a heterogeneous state of chronic intestinal inflammation with no exact known cause …

Background Restoring immune homeostasis by targeting the Th17/Treg response is a
potentially valuable therapeutic strategy for ulcerative colitis (UC). Astragaloside IV (AS-Ⅳ) …

Nuciferine (NCF) is an aporphine alkaloid and a principal bioactive constituent in the lotus
plant. Herewith, we investigated the potential anti-inflammatory effect and underlying …

In this study, we investigated the therapeutic effects and mechanism of atractylodin (ATL) on
dextran sulfate sodium (DSS)-induced ulcerative colitis in mice. We found that atractylodin …

Background Ulcerative colitis (UC) is a persistent inflammatory disorder that affects the
gastrointestinal tract, mainly the colon, which is defined by inflammatory responses and the …

As a chronic inflammatory bowel disease, ulcerative colitis (UC) imposes a significant
burden on public healthcare worldwide due to its increasing morbidity. Chinese medicines …